Company Perrigo Company plc

PRGO

IE00BGH1M568

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 02:53:59 2025-07-09 pm EDT			5-day change	1st Jan Change
27.20 ^USD	+0.24%		-0.15%	+5.87%

Jul. 01	Perrigo Company plc Announces Executive Changes	CI
Jun. 27	Perrigo Company plc Presents at UBS Global Consumer and Retail Conference 2025, Mar-12-2025 10:00 AM

Business description: Perrigo Company plc

Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.

Number of employees: 8,379

Sales by Activity: Perrigo Company plc

Fiscal Period: December	2020	2021	2022	2023	2024
Consumer Self-Care Americas (Csca)	2.69B	2.69B	2.93B	2.96B	2.69B
Consumer Self-Care International(Csci)	1.4B	1.45B	1.53B	1.69B	1.68B
Prescription Pharmaceuticals (rx)	975M	-	-	-	-

See all business segments

Geographical breakdown of sales: Perrigo Company plc

Fiscal Period: December	2020	2021	2022	2023	2024
United States (U.S.)	3.44B	2.57B	2.87B	2.92B	2.65B
Europe (Excl. Ireland)	1.32B	1.37B	1.44B	1.58B	1.56B
All Other Countries	272M	180M	107M	116M	120M
Ireland	29.8M	23.7M	29.3M	40.8M	39.6M

See all geographic segments

Executive Committee: Perrigo Company plc

Manager	Title	Age	Since
Patrick Lockwood-Taylor CEO	Chief Executive Officer	56	2023-06-29
Eduardo Bezerra DFI	Director of Finance/CFO	50	2022-05-15
Bradley Joseph IRC	Investor Relations Contact	-	2011-06-30
Robert Willis HRO	Human Resources Officer	56	2013-04-30

See PERRIGO COMPANY PLC governance

Composition of the Board of Directors: Perrigo Company plc

Director	Title	Age	Since
Donal O'Connor BRD	Director/Board Member	74	2014-10-31
Geoffrey Parker BRD	Director/Board Member	60	2016-11-06
Bradley Alford BRD	Director/Board Member	68	2017-02-05
Jeffrey Kindler BRD	Director/Board Member	69	2017-02-05
Adriana Karaboutis BRD	Director/Board Member	62	2017-05-01
Orlando Ashford CHM	Chairman	56	-
Albert A. Manzone BRD	Director/Board Member	62	2022-07-29
Patrick Lockwood-Taylor BRD	Director/Board Member	56	2023-06-29
Julia Brown BRD	Director/Board Member	55	2023-10-31
Jonas Samuelson BRD	Director/Board Member	57	2025-01-14

Composition of the Board of Directors

Shareholders: Perrigo Company plc

Name	Equities	%	Valuation
T. Rowe Price Associates, Inc. (IM) 10.43 %	14,232,241	10.43 %	380 M $
Vanguard Fiduciary Trust Co. 10.24 %	13,968,429	10.24 %	373 M $
BlackRock Advisors LLC 9.278 %	12,657,998	9.278 %	338 M $
T. Rowe Price International Ltd. 8.116 %	11,073,026	8.116 %	296 M $
DFA Australia Ltd. 5.043 %	6,879,491	5.043 %	184 M $

List of PERRIGO COMPANY PLC shareholders

Company details: Perrigo Company plc

Perrigo Co. Plc

The Sharp Building Hogan Place

2/74, Dublin

+353 1 709 4000

http://www.perrigo.com

Group companies: Perrigo Company plc

Name	Category and Sector
Rosemont Pharmaceuticals Ltd. Rosemont Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rosemont Pharmaceuticals Ltd. develops, manufactures, and supplies oral liquid medicines. Its product categories include anaesthesia, cardiovascular system, central nervous system, endocrine system, gastro-intestinal system, infections malignant disease and immunosuppression, musculoskeletal and joint disease, nutrition and blood, and PEG/NG tube administration guides. The company was founded in 1967 and is headquartered in Leeds, the United Kingdom.	Pharmaceuticals: Major
Omega Pharma Belgium NV Omega Pharma Belgium NV Medical DistributorsDistribution Services Part of Perrigo Co. Plc, Omega Pharma Belgium NV is a Belgian pharmaceutical company that supplies pharmaceuticals. The company is based in Nazareth, Belgium. The company was founded in 1977. Christophe van Damme has been the CEO of the company since 2020.	Medical Distributors
Perrigo Israel Pharmaceuticals Ltd. Perrigo Israel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Perrigo Israel Pharmaceuticals Ltd. develops and markets generic products, pharmaceutical ingredients, novel dermatological products, and consumer products. The firm operates manufacturing facilities in the United States, Israel, United Kingdom, Mexico, and Germany. The company was founded in 1983 and is headquartered in Bnei Braq, Israel	Pharmaceuticals: Major
Perrigo Investments LLC Perrigo Investments LLC Financial ConglomeratesFinance Part of Perrigo Co. Plc, Perrigo Investments LLC is a holding company. The company is based in Wilmington, DE.	Financial Conglomerates
Perrigo Israel Agencies Ltd. Perrigo Israel Agencies Ltd. Medical DistributorsDistribution Services Part of Perrigo Co. Plc, Perrigo Israel Agencies Ltd. is an Israeli company that distributes pharmaceutical products. The company is based in Bnei Braq, Israel.	Medical Distributors

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
PERRIGO COMPANY PLC	-0.15%	-0.33%	+2.57%	-35.29%	3.73B
ELI LILLY AND COMPANY	+1.10%	+1.01%	-15.58%	+137.77%	698B
JOHNSON & JOHNSON	-0.29%	-0.10%	+5.69%	-12.86%	375B
ABBVIE INC.	-0.16%	-0.47%	+12.97%	+23.90%	335B
NOVO NORDISK A/S	-1.53%	+0.35%	-54.14%	+9.26%	313B
ROCHE HOLDING AG	+0.89%	-0.04%	+6.30%	-20.36%	259B
NOVARTIS AG	-0.16%	-0.89%	+0.47%	+17.53%	240B
ASTRAZENECA PLC	+0.21%	-0.27%	-13.25%	-7.10%	217B
MERCK & CO., INC.	+2.81%	+1.69%	-33.53%	-11.16%	204B
AMGEN INC.	-0.06%	-0.08%	-6.11%	+19.71%	160B
Average	+0.25%	+0.41%	-9.46%	+12.14%	280.61B
Weighted average by Cap.	+0.31%	+0.40%	-10.80%	+35.78%